Alkeon Capital Management - RELMADA THERAPEUTICS INC ownership

RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 87 filers reported holding RELMADA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.38 and the average weighting 0.1%.

Quarter-by-quarter ownership
Alkeon Capital Management ownership history of RELMADA THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$2,621,000
+63.7%
100,000
+100.0%
0.00%
+100.0%
Q2 2021$1,601,000
-9.1%
50,0000.0%0.00%
-33.3%
Q1 2021$1,761,000
+9.8%
50,0000.0%0.00%0.0%
Q4 2020$1,604,00050,0000.00%
Other shareholders
RELMADA THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
VR Adviser, LLC 2,270,072$61,269,0009.93%
GREAT POINT PARTNERS LLC 790,000$21,322,0005.15%
ACUTA CAPITAL PARTNERS, LLC 342,000$9,231,0004.31%
COWEN AND COMPANY, LLC 1,164,361$31,426,0003.02%
Altium Capital Management LP 206,000$5,560,0001.86%
BVF INC/IL 1,647,400$44,463,0001.78%
RTW INVESTMENTS, LP 2,540,074$68,557,0001.42%
Vivo Capital, LLC 705,882$19,052,0001.31%
RA Capital Management 2,000,000$53,980,0001.18%
SPHERA FUNDS MANAGEMENT LTD. 291,252$7,861,0001.11%
View complete list of RELMADA THERAPEUTICS INC shareholders